• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Oral contraceptive use and incident urinary incontinence in premenopausal women.绝经前女性口服避孕药的使用与尿失禁的发生
J Urol. 2009 May;181(5):2170-5. doi: 10.1016/j.juro.2009.01.040. Epub 2009 Mar 17.
2
Postmenopausal hormone therapy and risk of developing urinary incontinence.绝经后激素治疗与尿失禁发生风险
Obstet Gynecol. 2004 Feb;103(2):254-60. doi: 10.1097/01.AOG.0000107290.33034.6f.
3
Associations Between Type and Route of Hormone Use on Urinary Incontinence and Pelvic Organ Prolapse in Premenopausal and Postmenopausal Women.激素使用类型和途径与绝经前及绝经后女性尿失禁和盆腔器官脱垂之间的关联
Female Pelvic Med Reconstr Surg. 2018 Mar/Apr;24(2):100-104. doi: 10.1097/SPV.0000000000000493.
4
Postmenopausal hormone therapy and incident urinary incontinence in middle-aged women.绝经后激素治疗与中年女性尿失禁的发生
Am J Obstet Gynecol. 2009 Jan;200(1):86.e1-5. doi: 10.1016/j.ajog.2008.08.009. Epub 2008 Nov 18.
5
Steroidal contraceptives and bone fractures in women: evidence from observational studies.甾体避孕药与女性骨折:来自观察性研究的证据。
Cochrane Database Syst Rev. 2015 Jul 21;2015(7):CD009849. doi: 10.1002/14651858.CD009849.pub3.
6
Steroidal contraceptives and bone fractures in women: evidence from observational studies.甾体避孕药与女性骨折:来自观察性研究的证据
Cochrane Database Syst Rev. 2012 Aug 15(8):CD009849. doi: 10.1002/14651858.CD009849.pub2.
7
Effect of raloxifene on urinary incontinence: a randomized controlled trial.雷洛昔芬对尿失禁的影响:一项随机对照试验。
Obstet Gynecol. 2004 Feb;103(2):261-6. doi: 10.1097/01.AOG.0000109429.67671.d1.
8
Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.联合和单纯孕激素激素避孕药与乳腺癌风险:一项英国巢式病例对照研究和荟萃分析。
PLoS Med. 2023 Mar 21;20(3):e1004188. doi: 10.1371/journal.pmed.1004188. eCollection 2023 Mar.
9
Breast cancer among young U.S. women in relation to oral contraceptive use.美国年轻女性乳腺癌与口服避孕药使用的关系。
J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. doi: 10.1093/jnci/86.7.505.
10
Urinary incontinence among Taiwanese women: an outpatient study of prevalence, comorbidity, risk factors, and quality of life.台湾女性尿失禁:一项门诊患病率、合并症、危险因素和生活质量的研究。
Int Urol Nephrol. 2009 Dec;41(4):795-803. doi: 10.1007/s11255-009-9523-3. Epub 2009 Feb 6.

引用本文的文献

1
Hormonal Contraception Use and Risk of Lower Urinary Tract Symptoms and Conditions: Findings From the Boston Area Community Health Survey.激素避孕的使用与下尿路症状及疾病风险:来自波士顿地区社区健康调查的结果
Int Urogynecol J. 2025 Aug 14. doi: 10.1007/s00192-025-06271-2.
2
Utility of opportunistic screening to assess the impact of urinary incontinence on quality of life and barriers to seeking treatment among women attending a tertiary healthcare centre in North India.在印度北部一家三级医疗中心就诊的女性中,机会性筛查在评估尿失禁对生活质量的影响及寻求治疗的障碍方面的效用。
BMC Urol. 2024 Mar 2;24(1):50. doi: 10.1186/s12894-024-01434-7.
3
Sexual Health Behaviors by Age 17 and Lower Urinary Tract Symptoms at Age 19: PLUS Research Consortium Analysis of ALSPAC Data.17 岁时的性行为和 19 岁时的下尿路症状:PLUS 研究联盟对 ALSPAC 数据的分析。
J Adolesc Health. 2023 May;72(5):737-745. doi: 10.1016/j.jadohealth.2022.12.019. Epub 2023 Feb 11.
4
Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review.多囊卵巢综合征与盆底功能障碍:一篇叙述性综述
Res Rep Urol. 2020 May 7;12:179-185. doi: 10.2147/RRU.S249611. eCollection 2020.
5
The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women.女性尿失禁与尿微生物组关联的当前证据。
Front Cell Infect Microbiol. 2019 May 1;9:133. doi: 10.3389/fcimb.2019.00133. eCollection 2019.
6
Risk factors for urinary incontinence among postmenopausal Mexican women.墨西哥绝经后女性尿失禁的危险因素
Int Urogynecol J. 2017 May;28(5):769-776. doi: 10.1007/s00192-016-3196-0. Epub 2016 Dec 16.
7
Hormonal contraception and pelvic floor function: a systematic review.激素避孕与盆底功能:一项系统综述
Int Urogynecol J. 2016 May;27(5):709-22. doi: 10.1007/s00192-015-2833-3. Epub 2015 Sep 25.
8
Prevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPINCONT).女性尿失禁的患病率、发病率及缓解情况:来自挪威HUNT研究(EPINCONT)的纵向数据
BMC Urol. 2013 May 30;13:27. doi: 10.1186/1471-2490-13-27.
9
Investigation of vaginal microbiota in sexually active women using hormonal contraceptives in Pakistan.调查使用激素避孕的巴基斯坦活跃性女性的阴道微生物群。
BMC Urol. 2012 Aug 18;12:22. doi: 10.1186/1471-2490-12-22.
10
Management of urinary incontinence.尿失禁的管理
P T. 2012 Jun;37(6):345-361H.

本文引用的文献

1
Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register.口服避孕药使用者出现尿失禁症状的风险:一项来自瑞典双胞胎登记处的全国队列研究。
Fertil Steril. 2009 Aug;92(2):428-33. doi: 10.1016/j.fertnstert.2008.07.002. Epub 2008 Aug 15.
2
Body shape throughout life and correlations with IGFs and GH.一生中的身体形态及其与胰岛素样生长因子(IGFs)和生长激素(GH)的相关性。
Endocr Relat Cancer. 2007 Sep;14(3):721-32. doi: 10.1677/ERC-06-0080.
3
Postmenopausal hormone therapy: does it cause incontinence?绝经后激素治疗:会导致尿失禁吗?
Obstet Gynecol. 2005 Nov;106(5 Pt 1):940-5. doi: 10.1097/01.AOG.0000180394.08406.15.
4
Effects of estrogen with and without progestin on urinary incontinence.雌激素联合或不联合孕激素对尿失禁的影响。
JAMA. 2005 Feb 23;293(8):935-48. doi: 10.1001/jama.293.8.935.
5
Postmenopausal hormone therapy and risk of developing urinary incontinence.绝经后激素治疗与尿失禁发生风险
Obstet Gynecol. 2004 Feb;103(2):254-60. doi: 10.1097/01.AOG.0000107290.33034.6f.
6
Urinary incontinence in the 12-month postpartum period.产后12个月内的尿失禁
Obstet Gynecol. 2003 Dec;102(6):1291-8. doi: 10.1016/j.obstetgynecol.2003.09.013.
7
Association of age, race, and obstetric history with urinary symptoms among women in the Nurses' Health Study.护士健康研究中女性年龄、种族及产科病史与泌尿系统症状的关联
Am J Obstet Gynecol. 2003 Aug;189(2):428-34. doi: 10.1067/s0002-9378(03)00361-2.
8
Menstrual cycle, female hormone use and urinary incontinence in premenopausal women.绝经前女性的月经周期、女性激素使用与尿失禁
Int Urogynecol J Pelvic Floor Dysfunct. 2003 Feb;14(1):56-61; discussion 61. doi: 10.1007/s00192-002-1012-5.
9
The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence.雌二醇对真性压力性尿失禁绝经后女性阴道胶原代谢的影响。
BJOG. 2002 Mar;109(3):339-44. doi: 10.1111/j.1471-0528.2002.01052.x.
10
Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women.美国女性队列中口服避孕药史的可重复性及所报告激素成分的有效性
Contraception. 1997 Dec;56(6):373-8. doi: 10.1016/s0010-7824(97)00172-8.

绝经前女性口服避孕药的使用与尿失禁的发生

Oral contraceptive use and incident urinary incontinence in premenopausal women.

作者信息

Townsend Mary K, Curhan Gary C, Resnick Neil M, Grodstein Francine

机构信息

Department of Medicine, Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Urol. 2009 May;181(5):2170-5. doi: 10.1016/j.juro.2009.01.040. Epub 2009 Mar 17.

DOI:10.1016/j.juro.2009.01.040
PMID:19296979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2712870/
Abstract

PURPOSE

Recent data in postmenopausal women indicate that current and past use of exogenous hormones is related to urinary incontinence risk. Little is known about exogenous hormones and risk of urinary incontinence in younger women. We investigated the association between oral contraceptive pills and incident urinary incontinence in premenopausal women enrolled in the Nurses' Health Study II.

MATERIALS AND METHODS

Participants reported use of oral contraceptive pills from 1989 to 2001. Among 21,864 premenopausal women 37 to 54 years old reporting no urinary incontinence in 2001 we identified 749 with incident urinary incontinence at least weekly between 2001 and 2003. Odds ratios and 95% confidence intervals were estimated using multivariable logistic regression.

RESULTS

Women who had ever used oral contraceptive pills had a statistically significant 27% (95% CI 1-59) increased odds of experiencing urinary incontinence at least weekly compared with those who never used oral contraceptive pills. In women with 10 or more years of use the odds ratio increased to 1.48 (95% CI 1.13-1.95). Ever using oral contraceptive pills was specifically associated with urgency urinary incontinence (OR 2.48, 95% CI 1.07-5.76) rather than stress urinary incontinence (OR 1.04, 95% CI 0.78-1.40). Although we had limited information on urinary tract infection, control for urinary tract infection did not alter these findings.

CONCLUSIONS

Use of oral contraceptive pills may be associated with a modest increase in the odds of urinary incontinence among premenopausal women. However, this is one of the first reports of such an association and, thus, further research is needed to confirm our findings and investigate possible mechanisms.

摘要

目的

绝经后女性的近期数据表明,目前及既往使用外源性激素与尿失禁风险相关。对于年轻女性中外源性激素与尿失禁风险的了解甚少。我们在参加护士健康研究II的绝经前女性中调查了口服避孕药与新发尿失禁之间的关联。

材料与方法

参与者报告了1989年至2001年期间口服避孕药的使用情况。在2001年报告无尿失禁的21864名37至54岁绝经前女性中,我们确定了749名在2001年至2003年期间至少每周发生一次新发尿失禁的女性。使用多变量逻辑回归估计比值比和95%置信区间。

结果

与从未使用过口服避孕药的女性相比,曾经使用过口服避孕药的女性至少每周经历一次尿失禁的几率在统计学上显著增加了27%(95%置信区间1-59)。在使用10年或更长时间的女性中,比值比增加到1.48(95%置信区间1.13-1.95)。曾经使用口服避孕药与急迫性尿失禁(比值比2.48,95%置信区间1.07-5.76)而非压力性尿失禁(比值比1.04,95%置信区间0.78-1.40)有特定关联。尽管我们关于尿路感染的信息有限,但对尿路感染进行控制并没有改变这些发现。

结论

口服避孕药的使用可能与绝经前女性尿失禁几率的适度增加有关。然而,这是关于这种关联的首批报告之一,因此,需要进一步研究来证实我们的发现并调查可能的机制。